Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.60 |
| ▸ | LTA4H | P09960 | 4/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.51 |
| ▸ | PLAAT3 | P53816 | 1/20 | 0.51 |
| ▸ | PLAAT5 | Q96KN8 | 1/20 | 0.51 |
| ▸ | PLAAT2 | Q9NWW9 | 1/20 | 0.51 |
| ▸ | PLAAT4 | Q9UL19 | 1/20 | 0.51 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19322273 | 1.00 | FFAR1 (0.60) | FFAR1LTA4HTSHRSRD5A2PLAAT3 | |
| SCHEMBL19322269 | 1.00 | FFAR1 (0.60) | FFAR1LTA4HTSHRSRD5A2PLAAT3 | |
| SCHEMBL12040543 | 0.98 | FFAR1 (0.58) | FFAR1LTA4HTSHRSRD5A2PLAAT3 | |
| SCHEMBL19322272 | 0.98 | FFAR1 (0.62) | FFAR1LTA4HTSHRSRD5A2PLAAT3 | |
| SCHEMBL2201304 | 0.93 | FFAR1 (0.62) | FFAR1LTA4HTSHRSRD5A2PLAAT3 | |
| SCHEMBL12056748 | 0.90 | LTA4H (0.62) | FFAR1LTA4H | |
| SCHEMBL8638619 | 0.90 | MAOA (0.64) | FFAR1LTA4H | |
| SCHEMBL22766219 | 0.90 | MAOA (0.64) | FFAR1LTA4H | |
| SCHEMBL5539299 | 0.90 | FFAR1 (0.51) | FFAR1LTA4HTSHRSRD5A2PLAAT3 | |
| SCHEMBL7364825 | 0.90 | FFAR1 (0.51) | FFAR1LTA4HTSHRSRD5A2PLAAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10450408-B2 | Method for making polyarylaliphaticetherketone polymers and copolymers thereof | KETONEX LIMITED (GB) | 2019-10-22 | — | — | US | disclosed |
| US-20170253696-A1 | METHOD FOR MAKING POLYARYLALIPHATICETHERKETONE POLYMERS AND COPOLYMERS THEREOF | OXFORD PERFORMANCE MATERIALS, INC | 2017-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10450408-B2 | Method for making polyarylaliphaticetherketone polymers and copolymers thereof | DAO, DCXR, LOX | FFAR1 1630/4885LTA4H 107/4885TSHR 1820/4885 |
| US-20170253696-A1 | METHOD FOR MAKING POLYARYLALIPHATICETHERKETONE POLYMERS AND COPOLYMERS THEREOF | COASY, FRK, PBK | FFAR1 1503/4885LTA4H 560/4885TSHR 2268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.